results

  • · Kishi T, Fukuo Y, Okochi T, Kitajima T, Kawashima K, Naitoh H, Ujike H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, and Iwata N.
    Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population. Drug Alcohol. Depend. 113, 1-7.2011
  • · Ide S, Minami M, Uhl GR, Satoh M, Sora I, and Ikeda K.
    (-)-Pentazocine induces visceral chemical antinociception, but not thermal, mechanical, or somatic chemical antinociception, in mu-opioid receptor knockout mice. Mol. Pain 7, 23.2011
  • · Yoshimura T, Usui H, Takahashi N, Yoshimi A, Saito S, Aleksic B, Ujike H, Inada T, Yamada M, Uchimura N, Iwata N, Sora I, Iyo M, and Ozaki N.
    Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1268-1272.2011
  • · Yamamoto H, Takamatsu Y, Imai K, Kamegaya E, Hagino Y, Watanabe M, Yamamoto T, Sora I, Koga H, and Ikeda K.
    Mop reduction during long-term methamphetamine withdrawal was restored by chronic post-treatment with fluoxetine. Curr. Neuropharmacol. 9, 73-78.2011
  • · Hagino Y, Takamatsu Y, Yamamoto H, Iwamura T, Murphy DL, Uhl GR, Sora I, and Ikeda K.
    Effect of MDMA on extracellular dopamine and serotonin levels in mice lacking dopamine and/or serotonin transporters. Curr. Neuropharmacol. 9, 91-95.2011
  • · Kasai S, Yamamoto H, Kamegaya E, Uhl GR, Sora I, Watanabe M, and Ikeda K.
    Quantitative detection of μ-opioid receptor: Western blot analyses using μ-opioid receptor knockout mice. Curr. Neuropharmacol. 9, 219-222.2011
  • · Komatsu H, Ohara A, Sasaki K, Abe H, Hattori H, Hall FS, Uhl GR, and Sora I.
    Decreased response to social defeat stress in μ-opioid-receptor knockout mice. Pharmacol. Biochem. Behav. 99, 676-682.2011
  • · Sogawa C, Sogawa N, Ohyama K, Kikura-Hanajiri R, Goda Y, Sora I, and Kitayama S.
    Methylone and monoamine transporters: correlation with toxicity. Curr. Neuropharmacol. 9, 58-62.2011
  • · Arime Y, Kubo Y, and Sora I.
    nimal models of attention-deficit/hyperactivity disorder. Biol. Pharm. Bull. 34, 1373-1376.2011
  • · Sora I .
    カテコールアミン神経伝達.認知症学(上)その解明と治療の最新知見. 日本臨床69増刊号8, 224-227.2011
  • · Sora I .
    シンポジウム特集「認知機能障害に対する治療をどう評価するか」. 日本神経精神薬理学雑誌 31, 239.2011
  • · 佐藤拓, 曽良一郎(Sora I).
    MATRICSコンセンサス認知機能評価バッテリー日本語版の開発への取り組み. 日本神経精神薬理学雑誌 31, 241-244.2011
  • · Sora I .
    ドーパミン受容体 Dopamine receptor. ストレス科学辞典. 日本ストレス学会/(財)パブリックヘルスリサーチセンター監修,実務教育出版,764.2011
  • · 曽良一郎(Sora I), 氏家寛.
    物質依存の神経化学. 脳とこころのプライマリケア第8巻 依存(福居顯二編集), シナジー, pp50-59.2011
  • · Sora I .
    LSD-25. 現代精神医学事典(加藤敏,神庭重信,中谷陽二,武田雅俊,鹿島晴雄,狩野力八郎,市川宏伸編), 弘文堂,116.2011
  • · Sora I .
    逆耐性現象. 現代精神医学事典(加藤敏,神庭重信,中谷陽二,武田雅俊,鹿島晴雄,狩野力八郎,市川宏伸編), 弘文堂, 215.2011
  • · Sora I .
    受容体. 現代精神医学事典(加藤敏,神庭重信, 中谷陽二, 武田雅俊,鹿島晴雄,狩野力八郎,市川宏伸編), 弘文堂, 470.2011
  • · Sora I .
    ドーパミン. 現代精神医学事典(加藤敏,神庭重信, 中谷陽二, 武田雅俊,鹿島晴雄,狩野力八郎,市川宏伸編), 弘文堂, 772.2011
  • · Sora I .
    ドーパミン仮説. 現代精神医学事典(加藤敏,神庭重信, 中谷陽二, 武田雅俊,鹿島晴雄,狩野力八郎,市川宏伸編), 弘文堂, 773,弘文堂.2011
  • · Sora I .
    モノアミン仮説. 現代精神医学事典(加藤敏,神庭重信, 中谷陽二, 武田雅俊,鹿島晴雄,狩野力八郎,市川宏伸編), 弘文堂, 1021-1022.2011
  • · Kobayashi H, Ujike H, Iwata N, Inada T, Yamada M, Sekine Y, Uchimura N, Iyo M, Ozaki N, Itokawa M, and Sora I.
    Association analysis of the Adenosine A1 receptor gene polymorphisms in patients with methamphetamine dependence/psychosis. Current Neuropharmacology.9, 137-142. 2010
  • · Kobayashi H, Ujike H, Iwata N, Inada T, Yamada M, Sekine Y, Uchimura N, Iyo M, Ozaki N, Itokawa M, and Sora I.
    Association analysis of the Tryptophan Hydroxylase 2 gene polymorphisms in patients with methamphetamine dependence/psychosis. Current Neuropharmacology.9, 176-182. 2010
  • · Arai M, Yuzawa H, Nohara I, Ohnishi T, Obata N, Iwayama Y, Haga S, Toyota T, Ujike H, Arai M, Ichikawa T, Nishida A, Tanaka Y, Furukawa A, Aikawa Y, Kuroda O, Niizato K, Izawa R, Nakamura K, Mori N, Matsuzawa D, Hashimoto K, Iyo M, Sora I, Matsushita M, Okazaki Y, Yoshikawa T, Miyata T, and Itokawa M.
    Enhanced carbonyl stress in a supopulation of schizophrenia. Arch Gen Psychiatry.67, 589-97. 2010
  • · Hall FS, Sora I, Perona MTG, and Uhl GR.
    The role of the serotonin transporter in drug reward: Gene knockout studies. In: Kaluev A (ed.) Experimental models in serotonin transporter research. New York: Nova Science Publishers., pp244-269.2010
  • · Li B, Arime Y, Hall F.S, Uhl G.R, Cui R, and Sora I..
    Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knock out mice. Eur. J. Pharmacol. 628, 104-107.2009.PMID: 19932884
  • · Sato T, Kaneda Y, Sumiyoshi C, Sumiyoshi T, and Sora I.
    MATRICSコンセンサス認知機能評価バッテリー(MCCB)の開発-統合失調症治療への導入を目指して-. 臨床精神薬理13,289-296.2010
  • · Kishi T, Tsunoka T, Ikeda M, Kitajima T, Kawashima K, Okochi T, Okumura T, Yamanouchi Y, Kinoshita Y, Ujike H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, and Iwata N.
    Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology 58, 452-456.2009.PMID: 19747927
  • · Sora I, Li B, Igari M, Hall FS, and Ikeda K.
    Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs. Ann. N.Y. Acad. Sci. Volume 1187 Addiction Reviews 2009, edited by George R. Uhl, Wiley-Blackwell, pp 218 -246.
  • · Ide S, Sora I, Ikeda K, Minami M, Uhl GR, and Ishihara K.
    Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice. Neuropharmacology. 58(1):241-247.2010.PMID: 19596019
  • · Frye CA , and Sora I.
    Progesterone reduces hyperactivity of female and male dopamine transporter knockout mice. Behav. Brain. Res. 209, 59-65.2010
  • · Tsunoka T Kishi T, Kitajima T, Okochi T, Okumura T, Yamanouchi Y, Kinoshita Y, Kawashima K, Naitoh H, Inada T, Ujike H, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, and Iwata N.
    Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population. Prog. Neuropsychopharmacol. Biol. Psychiatry. 34, 639-644.2010
  • · Okuyama K, Wada K, Sakurada S, Mizoguchi H, Komatsu H, Sora I, Tamura G, Ohkawara Y, Takayanagi M, and Ohno I.
    The Involvement of micro-Opioid Receptors in the Central Nervous System in the Worsening of Allergic Airway Inflammation by Psychological Stress in Mice. Int. Arch. Allergy. Immunol. 152, 342-352.2010
  • · Kobayashi H Ujike H, Iwata N, Inada T, Yamada M, Sekine Y, Uchimura N, Iyo M, Ozaki N, Itokawa M, and Sora I.
    The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population. Behav. Brain Funct. 6, 50.2010
  • · Ide S, Fujiwara S, Fujiwara M, Sora I, Ikeda K, Minami M, Uhl GR, and Ishihara K.
    Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice. J. Pharmacol. Sci. 114, 107-110.2010
  • · Kishi T, Kitajima T, Tsunoka T, Okumura T, Okochi T, Kawashima K, Inada T, Ujike H, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, and Iwata N.
    PROKR2 is associated with methamphetamine dependence in the Japanese population. Prog. Neuropsychopharmacol. Biol. Psychiatry. 34, 1033-1036.2010
  • · Ide S, Minami M, Sora I, and Ikeda K.
    Combination of cell culture assays and knockout mouse analyses for the study of opioid partial agonism. Pain and Analgesia. Methods Mol. Biol. 617, 363-74.2010
  • · 小林秀昭, 曽良一郎(Sora I).
    メタンフェタミン依存. 〜特集 精神疾患の遺伝子は、本当に見つかったのか?〜 分子精神医学10, 17-26.2010
  • · Sora I .
    薬物依存の脆弱性要因. 実験医学28, 38-42.2010
  • · 曽良一郎(Sora I), 久保有美子, 有銘預世布, 笠原好之, 佐藤拓.
    脳内報酬系を担うドーパミン神経伝達. 「ADHD薬物療法の新時代」. 現代のエスプリ 4, 124-133.2010
  • · Sora I .
    [国内学会トピックス]. 特集:統合失調症と生活習慣. 第19回日本臨床精神神経薬理学会・第39回日本神経精神薬理学会合同年会, Schizophrenia Frontier 11, 69-70.2010
  • · 曽良一郎(Sora I), 佐々木一益.
    痛みがあると薬物依存になりにくいというのは本当か? Clinical Neuroscience 別冊28, 581.2010
  • · 曽良一郎(Sora I), 内海修.
    シナプスの病態 薬物依存症. Clinical Neuroscience 28, 982-930.2010
  • · 笠原好之, 有銘預世布, 福井麻美, 内海修, 曽良一郎(Sora I).
    コカイン依存研究の動向.薬物依存の臨床各論−最新動向−. 日本臨床68, 1479-1485.2010
  • · 曽良一郎(Sora I), 石原佳奈, 笠原好之, 山本秀子, 池田和隆.
    中枢刺激薬の分子標的としてのモノアミントランスポーター. 実験行動薬理学(社団法人日本薬理学会編、武田弘志辻稔赤池昭紀編集), 金芳堂, pp263-271.2010
  • · Sora I .
    ドパミンと依存. 精神科臨床リュミエール16巻, 中山書店, pp204-205.2010
  • · Fukuda K, Hayashida M, Ide S, Saita N, Kokita Y, Kasai S, Nishizawa D, Ogai Y, Hasegawa J, Nagashima M, Tagami M, Komatsu H, Sora I, Koga H, Kaneko Y, and Ikeda K.
    Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery. Pain,147(1-3):194-201.2009.PMID: 19783098
  • · Koyama T, Mayahara T, Wakamatsu T, Sora I, and Fukuda K.
    Deletion of micro-opioid receptor in mice does not affect the minimum alveolar concentration of volatile anaesthetics and nitrous oxide-induced analgesia. Br J Anaesth. 103(5): 744-749.2009.PMID: 19767313
  • · Nishizawa D, Nagashima M, Katoh R, Satoh Y, Tagami M, Kasai S, Ogai Y, Han W, Hasegawa J, Shimoyama N, Sora I, Hayashida M, and Ikeda K.
    Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery. PLoS One.16;4(9):e7060.2009.PMID: 19756153
  • · Sora I, Komatsu H, Igari M, Ide S, Ikeda K, and shimoyama N.
    遺伝子多型とオピオイドの副作用〜特集:痛みと遺伝子多型〜 麻酔 58(9),1109-1111.
  • · Hall FS, Li XF, Randall-Thompson J, Sora I, Murphy DL, Lesch KP, Caron M, and Uhl GR.
    Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience. 162(4):870-80.2009.PMID: 19482066
  • · Sora I, Fukui A, Ikeda K, and Kasahara Y.
    Atomoxetineのプロフィールと薬理作用〜特集 Atomoxetineの導入でAD/HD治療はどう変わるか?〜 臨床精神薬理 12(9),1951-1956.
  • · Kotaka T, Ujike H, Okahisa Y, Takaki M, Nakata K, Kodama M, Inada T, Yamada M, Uchimura N, Iwata N, Sora I, Iyo M, Ozaki N, and Kuroda S.
    G72 gene is associated with susceptibility to methamphetamine psychosis. Prog Neuropsychopharmacol Biol Psychiatry. 33(6):1046-9.2009.PMID: 19482054
  • · Okochi T, Kishi T, Ikeda M, Kitajima T, Kinoshita Y, Kawashima K, Okumura T, Tsunoka T, Inada T, Yamada M, Uchimura N, Iyo M, Sora I, Ozaki N, Ujike H, and Iwata N.
    Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 1;33(5):903-5.2009.PMID: 19394386
  • · Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Tsunoka T, Okumura T, Inada T, Ujike H, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, and Iwata N.
    A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis. Prog Neuropsychopharmacol Biol Psychiatry. 1;33(5):895-8.2009.PMID: 19386276
  • · Tomita H, Tanaka C, Yu Z, Komatsu H, Kimura K, Sora I, Helen B.K, and William E.B.
    気分安定薬奏功機序解明のための包括的遺伝子発現解析 臨床薬理の進歩 30,52-59.
  • · Sora I, Li B, Fumushima S, Fukui A, Arime Y, Kasahara Y, Tomita H, and Ikeda K.
    Monoamine transporter as a target molecule for psychostimulants. Int Rev Neurobiol 85, 29-33.2009.PMID: 19607959
  • · Sora I, Kasahara Y, Uchiumi O, Kubo Y, Tomita H, and Ikeda K.
    AD/HDの遺伝要因解明の現状 分子精神医学 9(3),262-267.
  • · Ujike H, Katsu T, Okahisa Y, Takaki M, Kodama M, Inada T, Uchimura N, Yamada M, Iwata N, Sora I, Iyo M, Ozaki N, and Kuroda S.
    Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis. Prog Neuropsychopharmacol Biol Psychiatry. 15;33(4):625-9.2009.PMID: 19275926
  • · Okahisa Y, Ujike H, Kotaka T, Morita Y, Kodama M, Inada T, Yamada M, Iwata N, Iyo M, Sora I, Ozaki N, and Kuroda S.
    Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence. Psychiatry Clin Neurosci. 63(3):417-22.2009.PMID: 19566775
  • · Asada M, Ebihara S, Yamanda S, Niu K, Okazaki T, Sora I, and Arai H.
    Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation. Neoplasia 11, 408-417.2009.PMID: 19308295
  • · Hashimoto K, Amano T, Kasakura A, Uhl GR, Sora I, Sakai N, Kuzumaki N, Suzuki T, and Narita M.
    μ-opioid receptor-independent fashion of the suppression of sodium currents by μ-opioid analgesics in thalamic neurons. Neurosci Lett. 27;453(1):62-7.2009.
  • · Nakamura K, Sekine Y, Takei N, Iwata Y, Suzuki K, Anitha A, Inada T, Harano M, Komiyama T, Yamada M, Iwata N, Iyo M, Sora I, Ozaki N, Ujike H, and Mori N.
    An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis. Neurosci Lett. 15;455(2):120-3.2009.PMID: 19368859
  • · Kanahara N, Miyatake R, Sekine Y, Inada T, Ozaki N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iyo M, and Hashimoto K.
    Association study between the PIK4CA gene and methamphetamine use disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet. 5;150B(2):233-8.
  • · Ikeda K, Takamatsu Y, Hagino Y, and Sora I.
    メチルフェニデートの精神神経系に及ぼす影響 日本神経精神薬理学雑誌 29,121-123.
  • · Sora I , and Kasahara Y.
    トランスポーターの遺伝子改変動物と精神神経疾患. 中枢神経系のトランスポーターをめぐって. Clinical Neuroscience, 10(26) :1081-1083. 2008
  • · Sora I , and Fukui A.
    注意欠陥多動性障害(ADHD)とモノアミントランスポーター. 中枢神経系のトランスポーターをめぐって. Clinical Neuroscience, 10(26) :1146-1147. 2008
  • · Perona MT, Waters S, Hall FS, Sora I, Lesch KP, Murphy DL, Caron M , and Uhl GR.
    Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behavioural Pharmacology, 19:566-574.2008.
  • · Asada M, Ebihara S, Numachi Y, Okazaki T, Yamanda S, Ikeda K, Yasuda H, Sora I , and Arai H.
    Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter. Int J Cancer, 123:511-518.2008.PMID: 18470912
  • · Ito M, Numachi Y, Ohara A , and Sora I.
    Hyperthermic and lethal effects of methamphetamine: roles of dopamine D1 and D2 receptors. Neurosci Lett .27, 438:327-329.2008.PMID: 18486343
  • · Iwakura Y, Nawa H, Sora I , and Chao MV.
    Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. Journal of Biological Chemistry, 283:15799-15806.2008.PMID: 18381284
  • · Sora I .
    特集 II AD/HDの新しい薬物療法. メチルフェニデートの依存リスク. 精神科,12(4):310-315. 2008
  • · Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, Ujike H, Komiyama T, Harano M, Sekine Y , Inada T, Ozaki N, Iyo M, Iwata N, Yamada M, Sora I, Chen CK, Liu HC, and Lin SK.
    Genome-wide association for methamphetamine dependence: convergent results from two samples. Arch Gen Psychiatry. 2008 Mar;65(3):345-55.
  • · Ide S, Minami M, Ishihara K, Uhl GR, Satoh M, Sora I, and Ikeda K.
    Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout mice. Neuropharmacology, 54:1182-1188.2008.PMID: 18417173
  • · Kishimoto M, Ujike H, Motohashi Y, Tanaka Y, Okahisa Y, Kotaka T, Harano M, Inada T, Yamada M, Komiyama T, Hori T, Sekine Y, Iwata N, Sora I, Iyo M, Ozaki N, and Kuroda S.
    The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry15;63(2):191-196 (2008)
  • · Otani K, Ujike H, Sakai A, Okahisa Y, Kotaka T, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, and Kuroda S.
    Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence. Neurosci Lett. 2008 Mar 21;434(1):88-92. Epub 2008 Jan 19.
  • · Hashimoto T, Hashimoto K, Miyatake R, Matsuzawa D, Sekine Y, Inada T, Ozaki N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, and Iyo M.
    Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147, B7, 1040-1046. 2008 Jan 9. [Epub ahead of print]
  • · Morita Y, Ujike H, Tanaka Y, Kishimoto M, Okahisa Y, Kotaka T, Harano M, Inada T, Komiyama T, Hori T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N , and Kuroda S.
    The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder. Am J Med Genet B Neuropsychiatr Genet, 147 (1), ,54-58.2008.PMID: 17582620
  • · Kishimoto M, Ujike H, Okahisa Y, Kotaka T, Takaki M, Kodama M, Inada T, Yamada M, Uchimura N, Iwata N, Sora I, Iyo M, Ozaki N, and Kuroda S.
    The Frizzled 3 Gene Is Associated with Methamphetamine Psychosis in Japanese Population Behav. Brain Funct. 4, 1, 37.2008
  • · Hayashida M, Nagashima M, Satoh Y, Katoh R, Tagami M, Ide S, Kasai S, Nishizawa D, Ogai Y, Hasegawa J, Komatsu H, Sora I, Fukuda K, Koga H, Hanaoka K, and Ikeda K.
    Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 9, 1605-1616.2008
  • · Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, and Iwata N.
    Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population. Ann. N.Y. Acad. Sci. 1139, 63-69.2008
  • · Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, and Iwata N.
    Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population. Ann. N.Y. Acad. Sci. 1139, 70-82.2008
  • · Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, and Iwata N.
    Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese population. Ann. N.Y. Acad. Sci. 1139, 83-88.2008
  • · Kinoshita Y, Ikeda M, Ujike H, Kitajima T, Yamanouchi Y, Aleksic B, Kishi T, Kawashima K, Ohkouchi T, Ozaki N, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Sekine Y, Iyo M, Sora I, and Iwata N.
    Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population. Ann. N.Y. Acad. Sci.1139, 57-62.2008
  • · Ezaki N, Nakamura K, Sekine Y, Thanseem I, Anitha A, Iwata Y, Kawai M, Takebayashi K, Suzuki K, Takei N, Iyo M, Inada T, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, and Mori N.
    Short allele of 5-HTTLPR as a risk factor for the development of psychosis in Japanese methamphetamine abusers. Ann. N.Y. Acad. Sci.1139, 49-56.2008
  • · 曽良一郎(Sora I), 猪狩もえ, 池田和隆.
    薬物依存とメチルフェニデート. シンポジウム「AD/HDの薬物療法-メチルフェニデートを巡って-」 精神神経学雑誌 110, 941-945.2008
  • · Sora I. .
    薬物依存 生物学的側面. 精神医学対話(松下正明, 加藤敏, 神庭重信編) , 弘文堂, 831-840.2008
  • · 奥山眞紀子, 曽良一郎(Sora I).
    [監修] AD/HDを理解するための講演キット「発達過程からみたメチルフェニデートの依存リスク」. 日本AD/HD研究会編, アルタ出版株式会社.2008
  • · Arai M, Obata N, Kockelkorn TT, Yamada K, ToyotaT, Haga S, Yoshida Y, Ujike H, Sora I, Ikeda K, Yoshikawa T, and Itokawa M.
    Lack of association between polymorphisms in the 5' upstream region of the DISC1 gene and mood disorders. Psychiatric Genetics 2007 Dec;17(6):357
  • · Fukushima S, Shen H, Hata H, Ohara A, Ohmi K, Ikeda K, Numachi Y, Kobayashi H, Hall FS, Uhl GR, and Sora I..
    Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. Psychopharmacology193(1):55-62(2007)
  • · Sora I, Igari M, Yamamoto H , and Ikeda K.
    依存性薬物の分子標的としてのモノアミントランスポーター. 日本薬理学雑誌 130(6):450-454.2007
  • · Kasai S, Hayashida M, Sora I, and Ikeda K.
    Candidate gene polymorphisms predicting individual sensitivity to opioids. Naunyn Schmiedebergs Arch Pharmacol.377, 269-281.2007 Nov 13 [Epub ahead of print]
  • · Numachi Y, Ohara A, Yamashita M, Fukushima S, Kobayashi H, Hata H, Watanabe H, Hall FS, Lesch KP, Murphy DL, Uhl GR, and Sora I..
    Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol572: 120-128(2007)
  • · Job MO, Tang A, Hall FS, Sora I, Uhl GR, Bergeson SE, and Gonzales RA.
    Mu opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasis. Biol Psychiatry62 (6): 627-634 (2007)
  • · Sora I .
    オピオイド受容体Opioid receptor. In: KEY WORD 精神,第4版,(樋口輝彦,神庭重信,染矢俊幸,宮岡等編): 150-151, 先端医学社
  • · Sora I, Fukushima S, Yamamoto H, and Ikeda K.
    ADHD動物モデルとしてのドーパミントランスポーター欠損マウス. シンポジウム4 AD/HD研究の新機軸-基礎と臨床のクロストーク-. 脳と精神の医学 18(4):279-283.2007
  • · Matsuzawa D, Hashimoto K, Miyatake R, Shirayama Y, Shimizu E, Maeda K, Suzuki Y, Mashimo Y, Sekine Y, Inada T, Ozaki N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Hata A, Sawa A, and Iyo M.
    Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. American Journal of Psychiatry164: 1105-1114(2007)
  • · Sora I .
    薬物依存の分子病態. 実験医学25(13):179-184.2007
  • · Yamamoto H, Kamegaya E, Hagino Y, Imai K, Fujikawa A, Tamura K, Enokiya T, Yamamoto T, Takeshima T, Koga H, Uhl GR, Ikeda K, and Sora I.
    Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture. Neurochem Int 51:237-244.2007.PMID: 17664021
  • · Ikeda M, Ozaki N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Kishi T, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Inada T, and Iwata N.
    Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav6 (1):107-112 (2007)
  • · Doi N, Itokawa M, Hoshi Y, Arai M, Furukawa A, Hiroshi Ujike H, Sora I, and Yoshikawa T.
    A resistance gene in disguise for schizophrenia? Am J Med Genet B Neuropsychiatr Genet. 144, 165-173.2007
  • · Harburg GC, Hall FS, Harrist AV, Sora I, Uhl GR, and Eisch AJ.
    Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. Neuroscience 144, 77-87.2007
  • · Numachi Y, Shen H, Yoshida S, Fujiyama K, Toda S, Matsuoka H, Sora I, and Sato M.
    Methamphetamine alters expression of DNA methyltransferase 1 mRNA in rat brain. Neurosci. Lett. 414, 213–217.2007
Copyright © Tohoku Univ. All Rights Reserved.